Johnson Financial Group Inc (Wisconsin)’s Anika Therapeutics ANIK Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-500	Closed	-$22K	–	554
2017 Q1	$22K	Hold	500	–	–	﹤0.01%	502
2016 Q4	$24K	Buy	500 +250	+100%	+$11.6K	﹤0.01%	487
2016 Q3	$12K	Sell	250 -250	-50%	-$12.3K	﹤0.01%	569
2016 Q2	$27K	Hold	500	–	–	﹤0.01%	525
2016 Q1	$22K	Sell	500 -275	-35%	-$11.2K	﹤0.01%	485
2015 Q4	$30K	Sell	775 -1,600	-67%	-$61.2K	0.01%	456
2015 Q3	$76K	Hold	2,375	–	–	0.02%	395
2015 Q2	$78K	Hold	2,375	–	–	0.02%	425
2015 Q1	$98K	Buy	2,375 +400	+20%	+$16.2K	0.02%	386
2014 Q4	$80K	Buy	1,975 +750	+61%	+$29.3K	0.02%	405
2014 Q3	$45K	Buy	+1,225	New	+$52.9K	0.01%	458

Other funds holding ANIK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s ANIK Position: Q2 2017 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Anika Therapeutics (ANIK) in Q2 2017, closing a stake of 500 shares — an estimated $22K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in ANIK in Q3 2014 and held it in 11 quarters. The position peaked at $98K in Q1 2015. 159 funds tracked by Wall St. Rank hold ANIK as of Q2 2017.

Johnson Financial Group Inc (Wisconsin) reported no remaining Anika Therapeutics position as of Q2 2017 after selling out during the quarter.
Johnson Financial Group Inc (Wisconsin) sold 500 Anika Therapeutics shares in Q2 2017, an estimated $22K.
Johnson Financial Group Inc (Wisconsin) first reported a position in Anika Therapeutics in Q3 2014 and held it in 11 quarters.
Johnson Financial Group Inc (Wisconsin)'s Anika Therapeutics position peaked at $98K in Q1 2015.
159 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2017.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2017, filed 10 Aug 2017.